Literature DB >> 28981171

Construction of tissue-engineered lymphatic vessel using human adipose derived stem cells differentiated lymphatic endothelial like cells and decellularized arterial scaffold: A preliminary study.

Yi Yang1, Jian-Tao Yang1, Xiao-Hu Chen2, Ben-Gang Qin1, Fu-Gui Li3, Yun-Xian Chen4, Li-Qiang Gu1, Jia-Kai Zhu1, Ping Li1.   

Abstract

We have previously demonstrated that human adipose-derived stem cells (hADSCs) can be differentiated into lymphatic endothelial like cells. The purpose of this study was to investigate the feasibility of utilizing the induced lymphatic endothelial like cells and decellularized arterial scaffold to construct the tissue-engineered lymphatic vessel. The hADSCs were isolated from adipose tissue in healthy adults and were characterized the multilineage differentiation potential. Decellularized arterial scaffold was prepared using the Triton x-100 method. ADSCs were differentiated into lymphatic-like endothelial cells, and the induced cells were then seeded onto the decellularized arterial scaffold to engineer the lymphatic vessel. The histological analyses were performed to examine the endothelialized construct. The decellularized arterial scaffold was successfully obtained and was able to maintain its vessel morphology. The isolated ADSCs can be differentiated into osteocytes and adipocytes. After seeding onto the scaffold, the seeded cells attached and grew well on the decellularized arterial scaffold. Our preliminary results demonstrated that the induced lymphatic endothelial like cells combined with decellularized arterial scaffold could be utilized to successfully engineer the lymphatic vessel. Our findings may be helpful for the development of tissue-engineering of the lymphatic graft.
© 2017 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  adipose-derived stem cells; decellularized arterial scaffold; lymphatic vessel

Mesh:

Year:  2017        PMID: 28981171     DOI: 10.1002/bab.1618

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  4 in total

1.  Modeling Immunity In Vitro: Slices, Chips, and Engineered Tissues.

Authors:  Jennifer H Hammel; Sophie R Cook; Maura C Belanger; Jennifer M Munson; Rebecca R Pompano
Journal:  Annu Rev Biomed Eng       Date:  2021-04-19       Impact factor: 11.324

2.  Delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema.

Authors:  Bohan Li; Jiantao Yang; Raoping Wang; Jia Li; Xubo Li; Xiang Zhou; Shuai Qiu; Ricong Weng; Zichao Wu; Chunyuan Tang; Ping Li
Journal:  Ann Transl Med       Date:  2020-11

Review 3.  Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema.

Authors:  Cynthia J Sung; Kshitij Gupta; Jin Wang; Alex K Wong
Journal:  Bioengineering (Basel)       Date:  2022-04-06

4.  The importance of factorial design in tissue engineering and biomaterials science: Optimisation of cell seeding efficiency on dermal scaffolds as a case study.

Authors:  Alexandra Levin; Vaibhav Sharma; Lilian Hook; Elena García-Gareta
Journal:  J Tissue Eng       Date:  2018-06-25       Impact factor: 7.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.